Literature DB >> 1661093

A model of beta-adrenergic effects on calcium and potassium current in bullfrog atrial myocytes.

J M Shumaker1, J W Clark, W R Giles.   

Abstract

A model of beta-adrenergic and muscarinic cholinergic effects on the bullfrog atrial myocyte has been developed to simulate the dose-dependent effects of isoprenaline (Iso) on the action potential duration (APD); i.e., low doses of Iso lengthen the APD, whereas high doses shorten the APD. In this model, the reduction in APD is the result of 1) calcium-dependent inactivation of calcium current (ICa) resulting from the enhancement of ICa by Iso and 2) an enhancement of potassium current (IK) due to both an Iso-induced increase in the rate of activation of IK and an increase in peak action potential height. The effect of acetylcholine (ACh) is simulated by a reduction in the Iso-induced increase in ICa and IK through a reduction in relative adenosine 3',5'-cyclic monophosphate concentration ([cAMP]), as well as activation of the ACh-sensitive potassium current. At low [Iso] levels in the presence of a high [ACh], the muscarinic cholinergic effects dominate the beta-adrenergic change. However, for a large [Iso] and a small [ACh], this pattern of changes in transmembrane currents is different; in this case the model predicts that ACh can actually increase APD.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1661093     DOI: 10.1152/ajpheart.1991.261.6.H1937

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  2 in total

1.  Effects of acetylcholine and noradrenalin on action potentials of isolated rabbit sinoatrial and atrial myocytes.

Authors:  Arie O Verkerk; Guillaume S C Geuzebroek; Marieke W Veldkamp; Ronald Wilders
Journal:  Front Physiol       Date:  2012-05-31       Impact factor: 4.566

2.  Adult murine skeletal muscle contains cells that can differentiate into beating cardiomyocytes in vitro.

Authors:  Steve O Winitsky; Thiru V Gopal; Shahin Hassanzadeh; Hiroshi Takahashi; Divina Gryder; Michael A Rogawski; Kazuyo Takeda; Zu X Yu; Yu H Xu; Neal D Epstein
Journal:  PLoS Biol       Date:  2005-03-15       Impact factor: 8.029

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.